BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/1/2024 2:45:05 AM | Browse: 610 | Download: 1787
Publication Name World Journal of Clinical Cases
Manuscript ID 88475
Country China
Received
2023-10-08 01:56
Peer-Review Started
2023-10-08 01:58
First Decision by Editorial Office Director
2023-12-01 18:15
Return for Revision
2023-12-04 00:36
Revised
2024-01-02 02:50
Publication Fee Transferred
Editorial Processing by Scientific Editor
2024-02-05 02:43
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2024-02-05 06:56
Articles in Press
2024-02-05 06:56
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-02-25 05:39
Publish the Manuscript Online
2024-03-01 02:45
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports
Manuscript Source Unsolicited Manuscript
All Author List Dan Wu, Qiong Wang, Shuai Yan, Xia Sun, Ya Qin, Ming Yuan, Nan-Yao Wang and Xian-Ting Huang
ORCID
Author(s) ORCID Number
Qiong Wang http://orcid.org/0009-0001-1157-7302
Funding Agency and Grant Number
Funding Agency Grant Number
Wuxi Health and Health Committee MS201908
Corresponding Author Qiong Wang, MD, Chief Doctor, Professor, Department of Oncology, Jiangyin People's Hospital, No. 163, Shoushan Road, Wuxi 214400, Jiangsu Province, China. wangqiong55@hotmail.com
Key Words Pancreatic cancer; Anti-vascular endothelial growth factor receptor; Fruquintinib; Case report
Core Tip These two cases achieved a progress-free survival benefit from later-line single-agent fruquintinib therapy. With its better safety profile, fruquintinib may be worth exploring and studying in more depth as a later-line treatment for pancreatic cancer patients. This is the first literary report on Fruquintinib used in metastasis pancreatic cancers.
Publish Date 2024-03-01 02:45
Citation Wu D, Wang Q, Yan S, Sun X, Qin Y, Yuan M, Wang NY, Huang XT. Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports. World J Clin Cases 2024; 12(7): 1296-1304
URL https://www.wjgnet.com/2307-8960/full/v12/i7/1296.htm
DOI https://dx.doi.org/10.12998/wjcc.v12.i7.1296
Full Article (PDF) WJCC-12-1296-with-cover.pdf